Skip navigation

Chemical Carmustine

Name Carmustine
CAS Type 1 Name Urea, N,N'-bis(2-chloroethyl)-N-nitroso-
Equivalent Terms 1,3-Bis(2-Chloroethyl)-1-Nitrosourea | BCNU | BiCNU | FIVB | Nitrumon | N,N'-Bis(2-Chloroethyl)-N-Nitrosourea
CAS Registry Number 154-93-8
Definition A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
Structure Carmustine
Top Interacting
Genes
MeSH® ID D002330
External Links

Top ↑ Ancestors

1. ChemicalsOrganic Chemicals Has associated genes Has associated diseases Has associated exposure references Nitroso Compounds Has associated genes Has associated diseases Has associated exposure references Nitrosourea Compounds Has associated genes Has associated diseases Carmustine Has associated genes Has associated diseases
2. ChemicalsOrganic Chemicals Has associated genes Has associated diseases Has associated exposure references Urea Has associated genes Has associated diseases Has associated exposure references Nitrosourea Compounds Has associated genes Has associated diseases Carmustine Has associated genes Has associated diseases

Top ↑ Descendants

Carmustine Has associated genes Has associated diseases
  1,3-bis(3-chloro-2-butyl)-1-nitrosourea
  2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide Has associated genes Has associated diseases
  2-chloroethyl-N-nitrosourea hydrochloride
  ABCM protocol
  ABC protocol
  BACT protocol
  BAEC protocol Has associated genes Has associated diseases
  BAFMi protocol
  BAVC protocol
  BBVDD protocol
  BCHE protocol
  BCOMM protocol
  BCPP protocol
  BCP protocol
  BCVP protocol
  BEAM protocol
  BEAM regimen Has associated diseases
  BEM protocol
  BFHM protocol
  BMPD protocol
  BMP protocol
  BMVC protocol
  BOMES protocol
  BOPP protocol
  BVAM protocol
  BVCPP protocol Has associated diseases
  carmustine, poliferprosan 20 drug combination
  carmustine with prolifeprosan 20 Has associated diseases
  CBV protocol Has associated genes Has associated diseases
  DBCT protocol
  DBPT protocol
  DBPT regimen
  DEMOB protocol
  Dexa-BEAM protocol Has associated diseases
  EBAP protocol
  FAB protocol
  FBM protocol
  FIB-P protocol
  FIVB+P protocol
  FMB protocol
  ICBV regimen
  L-6 protocol
  M-2 protocol Has associated diseases
  MBCF protocol
  MBVP protocol
  N-chloroethylnitrosourea asparaginamide
  N-nitroso-tris-chloroethylurea
  PECC protocol
  STAMP-I protocol Has associated diseases
  UCH II protocol
  UCH I protocol
  VBAD protocol
  VBAMDex protocol
  VBAP protocol
  VDBCP protocol
  VP-BBML protocol